default author photo

Sean R.R. Hall

University of Bern - Deparment of General Thoracic Surgery

Harvard University

1875 Cambridge Street

Cambridge, MA 02138

United States

SCHOLARLY PAPERS

1

DOWNLOADS

74

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Therapeutic Targeting of MEK1/2 Synergizes with PARP1 Inhibitors in the Treatment of Malignant Pleural Mesothelioma

Number of pages: 38 Posted: 16 May 2022
University of Bern - Deparment of General Thoracic Surgery, University of Bern - Deparment of General Thoracic Surgery, University of Bern - Deparment of General Thoracic Surgery, University of Bern - Deparment of General Thoracic Surgery, University of Bern - Deparment of General Thoracic Surgery, University of Bern - Department of Medical Oncology, University of Bern - Deparment of General Thoracic Surgery, University of Bern - Department of Medical Oncology, University of Lausanne - Department of Laboratory Medicine and Pathology, Shanghai Jiao Tong University (SJTU), Shanghai Chest Hospital, Department of Thoracic Surgery, University of Bern - Department of Medical Oncology, University of Bern - Deparment of General Thoracic Surgery, University of Bern - Deparment of General Thoracic Surgery, University of Bern - Deparment of General Thoracic Surgery, University of Bern - Deparment of General Thoracic Surgery and University of Bern - Deparment of General Thoracic Surgery
Downloads 74 (860,052)

Abstract:

Loading...

Mesothelioma, targeted therapy, MEK1, PARP1, metabolic stress, synergy